163 related articles for article (PubMed ID: 29459429)
21. Epidemiology of sebaceous carcinoma of the head and neck: implications for lymph node management.
Tryggvason G; Bayon R; Pagedar NA
Head Neck; 2012 Dec; 34(12):1765-8. PubMed ID: 22267270
[TBL] [Abstract][Full Text] [Related]
22. Sebaceous carcinoma of the eyelids.
Hornblass A; Lauer SA
Ophthalmology; 2004 Dec; 111(12):2149-50. PubMed ID: 15582066
[No Abstract] [Full Text] [Related]
23. Risk Factors for Local Recurrence or Metastasis of Eyelid Sebaceous Gland Carcinoma After Wide Excision With Paraffin Section Control.
Takahashi Y; Takahashi E; Nakakura S; Kitaguchi Y; Mupas-Uy J; Kakizaki H
Am J Ophthalmol; 2016 Nov; 171():67-74. PubMed ID: 27590119
[TBL] [Abstract][Full Text] [Related]
24. Sebaceous carcinoma in Japanese patients: clinical presentation, staging and outcomes.
Watanabe A; Sun MT; Pirbhai A; Ueda K; Katori N; Selva D
Br J Ophthalmol; 2013 Nov; 97(11):1459-63. PubMed ID: 24037608
[TBL] [Abstract][Full Text] [Related]
25. Comparison of posterior lamellar resection versus lumpectomy for initial management of localized tarsal conjunctival sebaceous carcinoma in 54 cases.
Lally SE; Rao R; Shields JA; Shields CL
Indian J Ophthalmol; 2018 Sep; 66(9):1295-1300. PubMed ID: 30127144
[TBL] [Abstract][Full Text] [Related]
26. Sebaceous cell carcinoma of the ocular adnexa: clinical presentations, histopathology, and outcomes.
Song A; Carter KD; Syed NA; Song J; Nerad JA
Ophthalmic Plast Reconstr Surg; 2008; 24(3):194-200. PubMed ID: 18520834
[TBL] [Abstract][Full Text] [Related]
27. Eyelid carcinoma: An experience from a tertiary cancer center.
Thiagarajan S; Bahani A; Chaukar D; Dcruz AK
J Cancer Res Ther; 2020 Dec; 16(Supplement):S48-S52. PubMed ID: 33380651
[TBL] [Abstract][Full Text] [Related]
28. Sentinel lymph node biopsy in malignant eyelid tumor: hybrid single photon emission computed tomography/computed tomography and dual dye technique.
Vuthaluru S; Pushker N; Lokdarshi G; Kumar R; Bajaj MS; Kashyap S; Mathur S; Chawla B; Khurana S; Ghose S
Am J Ophthalmol; 2013 Jul; 156(1):43-49.e2. PubMed ID: 23628352
[TBL] [Abstract][Full Text] [Related]
29. Sebaceous carcinoma of the eyelid: a clinicopathological study.
Zürcher M; Hintschich CR; Garner A; Bunce C; Collin JR
Br J Ophthalmol; 1998 Sep; 82(9):1049-55. PubMed ID: 9893597
[TBL] [Abstract][Full Text] [Related]
30. Eyelid sebaceous gland carcinoma: An assessment of the T classification of the American Joint Committee of Cancer TNM staging system 8th versus 7th edition.
AlHammad F; Edward DP; Alkatan HM; Elkhamary S; Iuliano A; Maktabi A; Al-Horani SE; Al-Sheikh O; Al Hussain H; Strianese D
Eur J Ophthalmol; 2021 Jul; 31(4):2055-2063. PubMed ID: 32567368
[TBL] [Abstract][Full Text] [Related]
31. Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies at a cancer center.
Nijhawan N; Ross MI; Diba R; Ahmadi MA; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2004 Jul; 20(4):291-5. PubMed ID: 15266143
[TBL] [Abstract][Full Text] [Related]
32. Vimentin overexpression as a novel poor prognostic biomarker in eyelid sebaceous gland carcinoma.
Bhardwaj M; Sen S; Chosdol K; Bakhshi S; Pushker N; Sharma A; Kashyap S; Bajaj MS; Singh VK
Br J Ophthalmol; 2020 Jun; 104(6):879-884. PubMed ID: 30940620
[TBL] [Abstract][Full Text] [Related]
33. Validation Study of the AJCC Cancer Staging Manual, Eighth Edition, Staging System for Eyelid and Periocular Squamous Cell Carcinoma.
Xu S; Sagiv O; Rubin ML; Sa HS; Tetzlaff MT; Nagarajan P; Ning J; Esmaeli B
JAMA Ophthalmol; 2019 May; 137(5):537-542. PubMed ID: 30869769
[TBL] [Abstract][Full Text] [Related]
34. Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor γ in eyelid sebaceous gland carcinoma.
Jayaraj P; Sen S; Bhattacharya T; Arora J; Yadav S; Chhoker V; Kumar A; Dhanaraj PS; Yadavilli KS; Verma M
Histopathology; 2016 Aug; 69(2):268-75. PubMed ID: 26791964
[TBL] [Abstract][Full Text] [Related]
35. Noninvasive and curative radiation therapy for sebaceous carcinoma of the eyelid.
Hata M; Koike I; Omura M; Maegawa J; Ogino I; Inoue T
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):605-11. PubMed ID: 21300468
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant chemotherapy in the management of sebaceous gland carcinoma of the eyelid with regional lymph node metastasis.
Murthy R; Honavar SG; Burman S; Vemuganti GK; Naik MN; Reddy VA
Ophthalmic Plast Reconstr Surg; 2005 Jul; 21(4):307-9. PubMed ID: 16052148
[TBL] [Abstract][Full Text] [Related]
37. Malignant eyelid tumors in Hong Kong 1997-2009.
Mak ST; Wong AC; Io IY; Tse RK
Jpn J Ophthalmol; 2011 Nov; 55(6):681-5. PubMed ID: 21842179
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological features of considerable reduction in androgen receptor expression in sebaceous gland carcinoma of the eyelid.
Yunoki T; Miyakoshi A; Otsuka M; Hayashi A
Int Ophthalmol; 2019 Aug; 39(8):1703-1708. PubMed ID: 30027448
[TBL] [Abstract][Full Text] [Related]
39. Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid.
Husain A; Blumenschein G; Esmaeli B
Int J Dermatol; 2008 Mar; 47(3):276-9. PubMed ID: 18289332
[TBL] [Abstract][Full Text] [Related]
40. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
